Recent 8-K filings for MAZE

Each filing is summarized by an LLM — headline, three bullets, event type. The source document on EDGAR is one click away. See methodology.

• May 12, 2026 20:07 UTC earnings item 2.02item 9.01

  Maze Q1 net loss $24.2M; MZE829 reduces proteinuria 35.6% in Phase 2 AMKD trial

source · MAZE on sec.gov